GEMFIELDS GROUP LIMITED - Reviewed Interim Report for the six months to 30 June 2026
What this filing means
Gemfields' reviewed interim results confirm the numbers it guided five days ago: revenue of USD 106.0 million, EBITDA of USD 40.7 million, and a statutory loss per share of USDc 4.3 driven by a USD 125.2 million non-cash MRM impairment. The operational picture is genuinely mixed — Kagem produced good emeralds but faced margin pressure, while MRM's second plant is largely operational with early recovery signs that management itself says are too early to call sustainable.
Gemfields is telling the market what it already told it five days ago — the headline numbers are unchanged. The real story is underneath: the ruby mine that has been struggling is showing early signs of improvement, but the company itself says it is too soon to know if that improvement will last. The big loss comes from writing down the value of that mine on paper, not from cash leaving the business.
Bull case
- H1 2026 revenue was USD 106.0 million.
- H1 2026 EBITDA was USD 40.7 million.
- Adjusted headline earnings per share were USDc 0.6 in H1 2026.
- Free cash flow before working capital movements was USD 17.4 million in H1 2026.
- MRM’s second processing plant became largely operational and recent ruby recoveries showed early signs of improvement, though sustainability remains unconfirmed.
Bear case
- MRM remains the Group’s most significant operational and financial challenge because premium ruby recoveries remain scarce.
- The MRM impairment was a non-cash charge of USD 125.2 million and was the primary driver of statutory loss per share of USDc 4.3.
- It is too early to determine whether recent MRM recovery improvements are sustainable in grade or recoveries.
- Management said significant work remains before it can conclude that MRM has turned a corner, while sustainable profitability requires consistent execution over time.
AI-generated summary by SENS-AI, based on the original JSE SENS filing.
SENS-AI conclusion
A confirmation print, not a fresh signal. The trading statement of 25 September disclosed the same loss per share, headline earnings per share, and the USD 125.2 million MRM impairment, and the share had already risen 14% in the 20 days before this announcement. The underlying operating picture is genuinely mixed: EBITDA turned positive and free cash flow before working capital was USD 17.4 million, but MRM's recovery remains unproven and management is explicit that sustainable profitability requires consistent execution over time. So what: the market has already absorbed the headline numbers; the next real test is whether MRM's early recovery signs translate into sustained grade and volume improvements in H2 2026.
The next operational update is where the market will test whether MRM's early recovery signs become sustained grade and volume improvements.
Evidence from the filing
H1 2026 revenue was USD 106.0 million.
“Total revenue for the six months to 30 June 2026 of USD 106.0 million”
H1 2026 EBITDA was USD 40.7 million.
“EBITDA for the six months to 30 June 2026 of USD 40.7 million”
Adjusted headline earnings per share were USDc 0.6 in H1 2026.
“Adjusted Headline earnings / (loss) per share — 0.6”
Free cash flow before working capital movements was USD 17.4 million in H1 2026.
“Free cash flow before working capital movements for the six months to 30 June 2026 of USD 17.4 million”
MRM’s second processing plant became largely operational and recent ruby recoveries showed early signs of improvement, though sustainability remains unconfirmed.
“the second processing plant ("PP2") at MRM became largely operational and recent ruby recoveries have shown signs of improvement. However, it is too early to determine whether these results represent a sustainable improvement in grade and recoveries”
MRM remains the Group’s most significant operational and financial challenge because premium ruby recoveries remain scarce.
“The first half of 2026 was a difficult period for Gemfields, driven principally by the continued shortage of premium ruby recoveries at Montepuez Ruby Mining ("MRM"), which remains the Group's most significant operational and financial challenge”
The MRM impairment was a non-cash charge of USD 125.2 million and was the primary driver of statutory loss per share of USDc 4.3.
“Statutory loss per share of USDc 4.3 primarily driven by a non-cash impairment charge of USD 125.2 million, recognised in respect of MRM”
Management said significant work remains before it can conclude that MRM has turned a corner, while sustainable profitability requires consistent execution over time.
“significant work remains to be done before we can conclude that MRM has turned a corner”
More on Gemfields Group Limited
Related filings
More from GML
- GEMFIELDS GROUP LIMITED - Trading Statement for six months ended 30 June 2026
- GEMFIELDS GROUP LIMITED - Auction Results: Commercial-Quality Emeralds
- GEMFIELDS GROUP LIMITED - Operational Update to 30 June 2026
- GEMFIELDS GROUP LIMITED - Auction Results - Trade Select Ruby Auction and MRM Update
- GEMFIELDS GROUP LIMITED - Directorate Change
Other Results Announcement
- MSPMAS PLC - Short-form announcement: Audited consolidated financial results for the year to 30 June 2026
- CAPITEC BANK LIMITED - Publication of the Capitec Bank Interim Results for the Six Months Ended 31 August 2026 (2027 Half-Year Results)
- CPICAPITEC LIMITED - Unaudited Condensed Consolidated Financial Results And Ordinary Cash Dividend Declaration For The 6 Months Ended 31 August 2026
- MSTMUSTEK LIMITED - Short form announcement: Financial results for the year ended 30 June 2026 and cash dividend declaration
- SZKSAB ZENZELE KABILI HOLDINGS (RF) LIMITED - SABZK reviewed condensed interim financial statements for the six months ended 30 June 2026